National Research Corporation (NRC)
USD 17.18
(-2.83%)
USD 17.18
(-2.83%)
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2023 | 32.3 Million USD | 1235.43% |
| 2022 | -2.84 Million USD | 89.77% |
| 2021 | -27.81 Million USD | -581.38% |
| 2020 | -4.08 Million USD | -119.76% |
| 2019 | 20.65 Million USD | 321.54% |
| 2018 | -9.32 Million USD | 72.3% |
| 2017 | -33.66 Million USD | -10.97% |
| 2016 | -30.33 Million USD | 23.66% |
| 2015 | -39.74 Million USD | -5.38% |
| 2014 | -37.71 Million USD | -90.13% |
| 2013 | -19.83 Million USD | -577.98% |
| 2012 | 4.15 Million USD | 166.71% |
| 2011 | -6.22 Million USD | -267.67% |
| 2010 | -1.69 Million USD | 0.24% |
| 2009 | -1.69 Million USD | -148.85% |
| 2008 | 3.47 Million USD | 1059.68% |
| 2007 | -361.78 Thousand USD | -103.54% |
| 2006 | 10.21 Million USD | 1529.44% |
| 2005 | 627 Thousand USD | -49.97% |
| 2004 | 1.25 Million USD | -21.78% |
| 2003 | 1.6 Million USD | -61.72% |
| 2002 | 4.18 Million USD | -0.88% |
| 2001 | 4.22 Million USD | 90.91% |
| 2000 | 2.21 Million USD | -11.54% |
| 1999 | 2.5 Million USD | 152.08% |
| 1998 | -4.8 Million USD | -2.13% |
| 1997 | -4.7 Million USD | -67.86% |
| 1996 | -2.8 Million USD | 0.0% |
| 1995 | - USD | 0.0% |
| 1994 | - USD | 0.0% |
| 1993 | - USD | 0.0% |
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2024 Q1 | 40.37 Million USD | 24.99% |
| 2024 Q2 | 41.73 Million USD | 3.37% |
| 2024 Q3 | 50.17 Million USD | 20.21% |
| 2023 Q4 | 32.3 Million USD | 61.51% |
| 2023 FY | 32.3 Million USD | 1235.43% |
| 2023 Q3 | 20 Million USD | 889.93% |
| 2023 Q2 | -2.53 Million USD | 4.38% |
| 2023 Q1 | -2.64 Million USD | 6.92% |
| 2022 Q1 | -21.79 Million USD | 21.64% |
| 2022 Q2 | -8.54 Million USD | 60.82% |
| 2022 Q3 | -5.12 Million USD | 40.04% |
| 2022 Q4 | -2.84 Million USD | 44.44% |
| 2022 FY | -2.84 Million USD | 89.77% |
| 2021 Q4 | -27.81 Million USD | -11.71% |
| 2021 Q1 | -13.84 Million USD | -239.22% |
| 2021 Q2 | -20.29 Million USD | -46.58% |
| 2021 FY | -27.81 Million USD | -581.38% |
| 2021 Q3 | -24.89 Million USD | -22.67% |
| 2020 Q1 | 23.2 Million USD | 12.33% |
| 2020 Q2 | 20.63 Million USD | -11.06% |
| 2020 Q3 | 9.73 Million USD | -52.82% |
| 2020 Q4 | -4.08 Million USD | -141.93% |
| 2020 FY | -4.08 Million USD | -119.76% |
| 2019 Q4 | 20.65 Million USD | -22.79% |
| 2019 Q3 | 26.75 Million USD | -18.96% |
| 2019 Q2 | 33 Million USD | -8.43% |
| 2019 Q1 | 36.04 Million USD | 486.59% |
| 2019 FY | 20.65 Million USD | 321.54% |
| 2018 Q3 | 31.66 Million USD | -4.04% |
| 2018 Q4 | -9.32 Million USD | -129.45% |
| 2018 Q2 | 32.99 Million USD | 193.13% |
| 2018 Q1 | -35.42 Million USD | -5.22% |
| 2018 FY | -9.32 Million USD | 72.3% |
| 2017 Q4 | -33.66 Million USD | 0.89% |
| 2017 FY | -33.66 Million USD | -10.97% |
| 2017 Q1 | -31.83 Million USD | -4.95% |
| 2017 Q2 | -29.41 Million USD | 7.6% |
| 2017 Q3 | -33.97 Million USD | -15.47% |
| 2016 FY | -30.33 Million USD | 23.66% |
| 2016 Q1 | -20.15 Million USD | 49.29% |
| 2016 Q2 | -22.56 Million USD | -11.95% |
| 2016 Q3 | -26.41 Million USD | -17.09% |
| 2016 Q4 | -30.33 Million USD | -14.84% |
| 2015 FY | -39.74 Million USD | -5.38% |
| 2015 Q2 | -33.53 Million USD | -14.06% |
| 2015 Q4 | -39.74 Million USD | -27.49% |
| 2015 Q3 | -31.17 Million USD | 7.03% |
| 2015 Q1 | -29.39 Million USD | 22.05% |
| 2014 Q4 | -37.71 Million USD | -2.61% |
| 2014 Q2 | -22.16 Million USD | 8.35% |
| 2014 Q1 | -24.18 Million USD | -21.9% |
| 2014 FY | -37.71 Million USD | -90.13% |
| 2014 Q3 | -36.75 Million USD | -65.84% |
| 2013 Q2 | 912 Thousand USD | -69.41% |
| 2013 Q4 | -19.83 Million USD | -149.57% |
| 2013 Q1 | 2.98 Million USD | -28.17% |
| 2013 FY | -19.83 Million USD | -577.98% |
| 2013 Q3 | -7.94 Million USD | -971.49% |
| 2012 Q3 | -1.95 Million USD | 78.51% |
| 2012 Q2 | -9.07 Million USD | -56.47% |
| 2012 Q1 | -5.8 Million USD | -186.19% |
| 2012 Q4 | 4.15 Million USD | 312.82% |
| 2012 FY | 4.15 Million USD | 166.71% |
| 2011 Q4 | 6.72 Million USD | 254.87% |
| 2011 Q2 | -1.2 Million USD | -109.72% |
| 2011 Q1 | 12.39 Million USD | -1.98% |
| 2011 FY | -6.22 Million USD | -267.67% |
| 2011 Q3 | -4.34 Million USD | -260.88% |
| 2010 Q1 | -5.45 Million USD | -204.72% |
| 2010 FY | -1.69 Million USD | 0.24% |
| 2010 Q3 | -1.38 Million USD | 78.4% |
| 2010 Q4 | 12.64 Million USD | 1012.05% |
| 2010 Q2 | -6.41 Million USD | -17.68% |
| 2009 Q1 | 10.38 Million USD | -12.3% |
| 2009 Q2 | 416 Thousand USD | -96.0% |
| 2009 Q3 | -695 Thousand USD | -267.07% |
| 2009 Q4 | 5.2 Million USD | 849.21% |
| 2009 FY | -1.69 Million USD | -148.85% |
| 2008 Q4 | 11.84 Million USD | 2805.48% |
| 2008 Q3 | -437.81 Thousand USD | -122.48% |
| 2008 Q2 | 1.94 Million USD | -62.04% |
| 2008 Q1 | 5.13 Million USD | 1518.36% |
| 2008 FY | 3.47 Million USD | 1059.68% |
| 2007 FY | -361.78 Thousand USD | -103.54% |
| 2007 Q1 | 6.97 Million USD | -31.7% |
| 2007 Q2 | 4.64 Million USD | -33.49% |
| 2007 Q3 | 2.75 Million USD | -40.62% |
| 2007 Q4 | -361.78 Thousand USD | -113.13% |
| 2006 Q4 | 10.21 Million USD | 533.06% |
| 2006 FY | 10.21 Million USD | 1529.44% |
| 2006 Q1 | -830.9 Thousand USD | -232.52% |
| 2006 Q3 | 1.61 Million USD | -86.69% |
| 2006 Q2 | 12.12 Million USD | 1559.29% |
| 2005 Q4 | 627 Thousand USD | -83.27% |
| 2005 Q2 | 1.69 Million USD | 465.83% |
| 2005 Q1 | -463.97 Thousand USD | -137.02% |
| 2005 FY | 627 Thousand USD | -49.97% |
| 2005 Q3 | 3.74 Million USD | 120.79% |
| 2004 FY | 1.25 Million USD | -21.78% |
| 2004 Q4 | 1.25 Million USD | -47.65% |
| 2004 Q3 | 2.39 Million USD | 132.26% |
| 2004 Q2 | 1.03 Million USD | 572.75% |
| 2004 Q1 | -218 Thousand USD | -113.61% |
| 2003 Q1 | 3.88 Million USD | -7.16% |
| 2003 Q2 | 2.41 Million USD | -37.94% |
| 2003 Q3 | 1.13 Million USD | -53.13% |
| 2003 Q4 | 1.6 Million USD | 41.76% |
| 2003 FY | 1.6 Million USD | -61.72% |
| 2002 Q2 | 3.37 Million USD | -16.48% |
| 2002 Q3 | 3.54 Million USD | 5.07% |
| 2002 FY | 4.18 Million USD | -0.88% |
| 2002 Q4 | 4.18 Million USD | 17.94% |
| 2002 Q1 | 4.04 Million USD | -4.23% |
| 2001 Q2 | 4.22 Million USD | 55.18% |
| 2001 Q4 | 4.22 Million USD | 75.15% |
| 2001 Q3 | 2.41 Million USD | -43.0% |
| 2001 Q1 | 2.72 Million USD | 23.23% |
| 2001 FY | 4.22 Million USD | 90.91% |
| 2000 FY | 2.21 Million USD | -11.54% |
| 2000 Q1 | 3.74 Million USD | 49.6% |
| 2000 Q3 | 811.27 Thousand USD | -59.51% |
| 2000 Q4 | 2.21 Million USD | 172.6% |
| 2000 Q2 | 2 Million USD | -46.43% |
| 1999 Q1 | -600 Thousand USD | 87.5% |
| 1999 FY | 2.5 Million USD | 152.08% |
| 1999 Q2 | -2.4 Million USD | -300.0% |
| 1999 Q4 | 2.5 Million USD | 150.0% |
| 1999 Q3 | 1 Million USD | 141.67% |
| 1998 Q2 | -1.3 Million USD | 66.67% |
| 1998 FY | -4.8 Million USD | -2.13% |
| 1998 Q1 | -3.9 Million USD | 17.02% |
| 1998 Q4 | -4.8 Million USD | -500.0% |
| 1998 Q3 | -800 Thousand USD | 38.46% |
| 1997 FY | -4.7 Million USD | -67.86% |
| 1997 Q4 | -4.7 Million USD | 0.0% |
| 1996 FY | -2.8 Million USD | 0.0% |
| 1995 FY | - USD | 0.0% |
| 1994 FY | - USD | 0.0% |
| 1993 FY | - USD | 0.0% |
| Name | Net Debt | Net Debt Difference |
|---|---|---|
| Inovalon Holdings, Inc. | 773.42 Million USD | 95.823% |
| GE HealthCare Technologies Inc. | 7.36 Billion USD | 99.562% |
| Sharecare, Inc. | -125.84 Million USD | 125.669% |
| Progyny, Inc. | -77.9 Million USD | 141.464% |
| Aclarion, Inc. | 94.65 Thousand USD | -34027.093% |
| CareMax, Inc. | 426.4 Million USD | 92.424% |
| Simulations Plus, Inc. | -9.83 Million USD | 428.416% |
| CareCloud, Inc. | 11.4 Million USD | -183.31% |
| Forian Inc. | 16.95 Million USD | -90.479% |
| Bullfrog AI Holdings, Inc. Warrants | -2.62 Million USD | 1330.717% |
| Bullfrog AI Holdings, Inc. Common Stock | -2.62 Million USD | 1330.717% |
| Minerva Surgical, Inc. | 32.74 Million USD | 1.359% |
| Omnicell, Inc. | 113.11 Million USD | 71.441% |
| Definitive Healthcare Corp. | 136.95 Million USD | 76.413% |
| Zhongchao Inc. | -6.74 Million USD | 579.235% |
| Accolade, Inc. | 55.93 Million USD | 42.244% |
| Streamline Health Solutions, Inc. | 7.37 Million USD | -337.947% |
| Ontrak, Inc. | -8.01 Million USD | 503.183% |
| SOPHiA GENETICS SA | -104.65 Million USD | 130.868% |
| R1 RCM Inc. | 1.56 Billion USD | 97.938% |
| Spok Holdings, Inc. | -20.9 Million USD | 254.538% |
| Privia Health Group, Inc. | -381.22 Million USD | 108.474% |
| EUDA Health Holdings Limited | 3.18 Million USD | -914.057% |
| HeartBeam, Inc. | -16.18 Million USD | 299.537% |
| GeneDx Holdings Corp. | 20.08 Million USD | -60.799% |
| TruBridge, Inc. | 199.44 Million USD | 83.803% |
| Nutex Health, Inc. | 253.75 Million USD | 87.27% |
| Renalytix Plc | 3.85 Million USD | -737.951% |
| Sharecare, Inc. | -125.84 Million USD | 125.669% |
| Health Catalyst, Inc. | 142.79 Million USD | 77.378% |
| 10x Genomics, Inc. | -263.91 Million USD | 112.24% |
| GoodRx Holdings, Inc. | 38.77 Million USD | 16.689% |
| SCWorx Corp. | -1077.00 USD | 2999450.046% |
| Schrödinger, Inc. | -33.18 Million USD | 197.345% |
| HealthEquity, Inc. | 529.16 Million USD | 93.895% |
| HealthStream, Inc. | -17.11 Million USD | 288.774% |
| MSP Recovery, Inc. | 667.69 Million USD | 95.162% |
| Augmedix, Inc. | -20.49 Million USD | 257.606% |
| BrightSpring Health Services, Inc. Common Stock | 3.65 Billion USD | 99.117% |
| Ontrak, Inc. | -8.01 Million USD | 503.183% |
| SHL Telemedicine Ltd. | 13.15 Million USD | -145.499% |
| CareCloud, Inc. | 11.4 Million USD | -183.31% |
| Premier, Inc. | 855 Thousand USD | -3678.129% |
| Certara, Inc. | 63.24 Million USD | 48.921% |
| GeneDx Holdings Corp. | 20.08 Million USD | -60.799% |
| OneMedNet Corporation | 5.05 Million USD | -539.118% |
| BrightSpring Health Services, Inc. Tangible Equity Unit | 3.65 Billion USD | 99.117% |
| EUDA Health Holdings Limited | 3.18 Million USD | -914.057% |
| HeartBeam, Inc. | -16.18 Million USD | 299.537% |
| CareCloud, Inc. | 11.4 Million USD | -183.31% |
| Mangoceuticals, Inc. | -610.32 Thousand USD | 5392.728% |
| CareMax, Inc. | 426.4 Million USD | 92.424% |
| Healthcare Triangle, Inc. | 3.08 Million USD | -947.778% |
| Aclarion, Inc. | 94.65 Thousand USD | -34027.093% |
| OptimizeRx Corporation | 22.97 Million USD | -40.623% |